Hosted on MSN
Ketamine nasal spray will be subsidized for treatment-resistant depression—what you need to know about Spravato
An antidepressant containing a form of the drug ketamine has been added to the Pharmaceutical Benefits Scheme (PBS), making it much cheaper for the estimated 30,000 Australians with ...
Are you experiencing depression, anxiety, PTSD/PTSI, ADHD, or OCD? We can help. Stella Mental Health Boston specializes in Spravato (esketamine) nasal spray, transcranial magnetic stimulation (TMS), ...
Moment of Clarity has published a new educational article titled “Spravato for Bipolar Depression Treatment“, providing an in-depth exploration of how esketamine therapy is being used to manage ...
Jan. 21 (UPI) --The Food and Drug Administration has approved the first-ever stand-alone nasal spray to treat drug-resistant depression. Johnson & Johnson's Spravato has been approved to treat a major ...
The U.S. Food and Drug Administration (FDA) has approved Johnson & Johnson's nasal spray, Spravato (esketamine), as the first standalone therapy for adults suffering from major depressive disorder ...
Moment of Clarity has released a new resource titled “Is Spravato Covered by Insurance?“, now available on their website. The article provides clear guidance on how insurance providers may cover ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results